Organogenesis Holding (NASDAQ: ORGO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $115.5 million versus the consensus estimate of $122.05 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.